Morrisville, N.C.
Magellan Pharmaceutical Development, recently acquired by Cardinal Laboratories, will increase its Morrisville operations from 210,000 sf to approximately 360,000 sf. The $15- to $20-million expansion will occur over the next two to three years. Magellan will also utilize a 75,000-sf biotechnology plant purchased by Cardinal in north Raleigh to expand its Triangle services. Cardinal is also constructing an $80-million clinical manufacturing plant in Somerset, N.J. which will employ up to 300 workers. The plant is expected to reach full operations this fall.